Cytodyn Inc (CYDY)

[Bill_ENG]

This must really cause a pucker factor in the short sellers and BPs executives, although I dont know why, since these patients are receiving LL after Big Pharma's best and most expensive treatments fail.

They want to up the dosage because results aren't optimal. That is obvious. CytoDyn always has excuses. Nothing is ever their fault.
© 2021 InvestorsHub.com, Inc.

Living more than a year after they normally would be dead.

These people were final stage and had received the best the Oncology industry could do, with a safe drug which at the lower dose bought them a year, seem like it works well enough and proper dosing should improve on that.